Fulgent Genetics, Inc. Common Stock
Veridion Score
Composite trend over time
Why is FLGT moving today?
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for FLGT.
FLGT insider activity
Fulgent Genetics, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Net selling: -$6.0M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-02 | Xie Jian | Insider | sell | $17.89 | 2,146 | 367,605 | $38K | SEC Form 4 |
| 2026-06-03 | 2026-06-02 | Gao Hanlin | Insider | sell | $17.89 | 1,688 | 990,374 | $30K | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | Hsieh Ming | Insider | sell | $18.09 | 4,392 | 893,293 | $79K | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | Kim Paul | Insider | sell | $18.09 | 2,087 | 362,545 | $38K | SEC Form 4 |
| 2026-05-28 | 2026-05-27 | Xie Jian | Insider | sell | $17.60 | 1,201 | 369,751 | $21K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 66 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moFLGT contract awards, year to date.
Public federal awards linked to this ticker.
FLGT lobbying filings, year to date.
Registered lobbying filings matched to Fulgent Genetics, Inc. Common Stock.